Resource Library

View examples of how we address the unique need of every research question to deliver innovative, multidimensional solutions to convey the value of healthcare innovations. Download our posters from recent conferences or a list our publications.

European Congress of Rheumatology EULAR 2019Link
A SYSTEMATIC LITERATURE REVIEW OF HEALTHCARE BURDEN IN PATIENTS WITH BEHÇET’S DISEASEDownload
ISPOR HEOR TheaterLink
MAKING THE PATIENT VOICE COUNT – DEMONSTRATING WHEN, WHY, AND HOW TO ENGAGE PATIENTSDownload
Breakout Session PresentationsLink
AN UPDATED TWO-YEAR SURVIVAL ANALYSIS OF AXICABTAGENE CILOLEUCEL (AXI-CEL) IN RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA (R/R-LBCL)Download
A COMPARISON OF THE PARTITIONED SURVIVAL AND MULTI-STATE EXTRAPOLATION METHODS – A CASE STUDY BASED ON THE GASTRIC CANCER TRIAL ATTRACTION-2Download
ALEMTUZUMAB VERSUS GENERIC GLATIRAMER ACETATE 20 MG IN PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS – A COST-EFFECTIVENESS STUDY IN THE UNITED STATESDownload
GETTING THE MOST OUT OF VALUE BASED CONTRACTING FOR MEDICAL DEVICESDownload
ISPOR Annual 2019 PostersLink
COST-EFFECTIVENESS OF A 24-MONTH FIXED DURATION OF VENETOCLAX IN COMBINATION WITH RITUXIMAB IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA IN THE UNITED STATESDownload
ECONOMIC BURDEN ASSOCIATED WITH ADVERSE EVENTS AMONG PATIENTS WITH NON-METASTATIC PROSTATE CANCER TREATED WITH BICALUTAMIDE, ENZALUTAMIDE OR ABIRATERONE FOLLOWING ANDROGEN DEPRIVATION THERAPY (SURGICAL/MEDICAL CASTRATION).Download
CHARACTERISTICS AND TREATMENT PATTERNS FOR NON-METASTATIC CASTRATION RESISTANT PROSTATE CANCER (NMCRPC) PATIENTS IN GERMANY, FRANCE, AND UNITED KINGDOM (UK)Download
DIRECT COSTS AND HEALTHCARE RESOURCE USE AMONG PATIENTS NEWLY DIAGNOSED WITH ADVANCED UROTHELIAL CARCINOMADownload
UNBIASED TREATMENT EFFICACY DETECTION METHODS WHEN USING PATIENT REPORTED OUTCOMES IN SURVIVAL-DEPENDENT DROP-OUTDownload
QUALITY ADJUSTED TIME WITHOUT SYMPTOMS OF DISEASE PROGRESSION OR TOXICITY (Q-TWIST) OF NIVOLUMAB PLUS IPILIMUMAB (NIVO+IPI) VS SUNITINIB (SUN) AMONG UNTREATED ADVANCED RENAL CELL CARCINOMA (ARCC) PATIENTS (PATIENTS) WITH INTERMEDIATE OR POO …Download
COST-EFFECTIVENESS OF INHALED NITRIC OXIDE FOR TREATMENT OF INFANTS WITH HYPOXIC RESPIRATORY FAILURE- ADMINISTRATION AT HOSPITAL OF BIRTH VS. HELICOPTER TRANSFER TO ANOTHER HOSPITALDownload
ECONOMIC BURDEN ASSOCIATED WITH NON-COMMUNICABLE DISEASES AMONG ADULTS WITH DEPRESSION AND ANXIETY IN THE UNITED STATES.Download
PATIENT AND CAREGIVER PREFERENCES FOR CHARACTERISTICS OF TREATMENT IN HEMOPHILIA A- LITERATURE REVIEW AND QUALITATIVE RESEARCHDownload
A COST-UTILITY ANALYSIS OF TWO TRABECULAR MICRO-BYPASS STENTS IN PATIENTS WITH MILD-TO-MODERATE OPEN-ANGLE GLAUCOMA IN FRANCEDownload
SYSTEMATIC REVIEW AND BENCHMARKING OF US BUDGET IMPACT ANALYSESDownload
A NEWLY DEVELOPED POWER PROCEDURE FOR SAMPLE SIZE PLANNING IN COA VALIDATION STUDIESDownload
2019 AAN Annual MeetingLink
EARLY DETECTION OF PERSONS AT RISK FOR INCIDENT CM USING LONGITUDINAL CONFIRMATORY LATENT CLASS MODELS: RESULTS FROM THE AMERICAN MIGRAINE PREVALENCE AND PREVENTION (AMPP) STUDYDownload

Publications List

PublicationsLink
PUBLICATIONS BY SERVICE AREADownload
PUBLICATIONS BY THERAPEUTIC AREADownload
We help define, build, and communicate your product’s clinical, humanistic, and economic value through 4 Centers of Excellence
Modeling & Meta-Analysis

Modeling and Meta-Analysis

Developing tools to inform policy decision-makers about the clinical and health-economic consequences of health technologies

Patient-Centered Outcomes

Patient-Centered Outcomes

Including the patient perspective to better understand their needs, design better studies, and assess how they value different therapies

Real-World Evidence

Real-World
Evidence

Informing decision-making with evidence from “real-world” practice

Strategic Market Access

Strategic Market Access

Communicating the evidence regarding unmet needs and the benefits and costs of treatment innovation to ensure market access and reimbursement

Partner with Pharmerit

Partner with Pharmerit

Contact Us